The NeuroCircuit logo
The NeuroCircuit
Reading List
Subscribe
  • The NeuroCircuit
  • Topics
  • Clinical Trial News

Clinical Trial News

Insights and updates on ongoing and upcoming clinical trials in neurotech, including recruitment, findings, and innovations from around the globe.

Brain-to-VoiceClosed-loop DBSNeurotechnologyNeurohackingEthics & PolicyNeurorehabilitation & RoboticsNeuroscienceNeuralink Gene & Cell Therapies in NeurotechClinical Trial NewsIndustry & Leadership UpdatesBrain-Computer Interfaces (BCI)Sensory VR & BCIsNeural EngineeringEmerging TechNeurotech NewsNeural ImplantsInnovationDIY Neuro
NeurotechnologyNeurotechnology
+4+4
Weekly Signal: 34 | Speech BCIs, Craving Circuits, and Mental Privacy
Nov 22, 2025

Weekly Signal: 34 | Speech BCIs, Craving Circuits, and Mental Privacy

Signals shaping neurotech’s future

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+5+5
Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics
Nov 15, 2025

Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics

Decoding, biomarkers, and governance

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights
Nov 01, 2025

Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights

Clinical data, funding moves, and policy shifts

Ricardo Albornoz
Closed-loop DBSClosed-loop DBS
+6+6
Weekly Signal: 29 | Synapses, Stimulators & Safeguards
Oct 18, 2025

Weekly Signal: 29 | Synapses, Stimulators & Safeguards

Mechanisms, markets, and mental privacy

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 28 | Neural Interfaces Meet Empathy and Expansion
Oct 11, 2025

Weekly Signal: 28 | Neural Interfaces Meet Empathy and Expansion

From Parkinson’s progress to pain-sharing tech

Ricardo Albornoz
Closed-loop DBSClosed-loop DBS
+6+6
Weekly Signal: 27 | BCI Gains, DBS Updates & Policy
Oct 04, 2025

Weekly Signal: 27 | BCI Gains, DBS Updates & Policy

Clinical signals, market moves

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 26 |Gene Therapy, HD-EEG, and Neural Rights
Sep 27, 2025

Weekly Signal: 26 |Gene Therapy, HD-EEG, and Neural Rights

Clinical, industry, and policy signals

Ricardo Albornoz
Brain-to-VoiceBrain-to-Voice
+6+6
Weekly Signal: 25 | Imagined Speech & Neuromod Breakthroughs
Sep 20, 2025

Weekly Signal: 25 | Imagined Speech & Neuromod Breakthroughs

BCI Trials and Industry Milestones

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 24 | Therapies, Tracers & Tech Shifts
Sep 13, 2025

Weekly Signal: 24 | Therapies, Tracers & Tech Shifts

Clinical wins & data rules

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+5+5
Weekly Signal: 23 | Neurotech on the Edge: BCI Breakthroughs
Sep 07, 2025

Weekly Signal: 23 | Neurotech on the Edge: BCI Breakthroughs

Privacy, Therapy & Beyond

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+6+6
Weekly Signal 19 — Brain Models, Consciousness Probes & Neuro-Policy Shifts
Aug 10, 2025

Weekly Signal 19 — Brain Models, Consciousness Probes & Neuro-Policy Shifts

From lab breakthroughs to policy battles shaping neurotech’s future.

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal 18 | Brain Implants & Neuro-Rights
Aug 03, 2025

Weekly Signal 18 | Brain Implants & Neuro-Rights

From Stroke Recovery to Statewide Consent

Ricardo Albornoz
The NeuroCircuit delivers cutting-edge neurotechnology news, insights, and tools straight to the minds shaping the future.

The NeuroCircuit

The NeuroCircuit delivers cutting-edge neurotechnology news, insights, and tools straight to the minds shaping the future.

Home

Posts

NeuroCircuit Reading List

Reading List

© 2025 The NeuroCircuit.

Privacy policy

Terms of use

Powered by beehiiv